DRUG GUIDELINE

Lignocaine (Lidocaine) Intravenous And Endotracheal (Cardiac)
SCOPE (Area): Emergency, Operating Suite, ICU, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), Cardiovascular Suite, Coronory Care Unit
SCOPE (Staff): Medical, Nursing, Pharmacy
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice) and General Wards


Preamble

See Appendix for full version of this Drug Guideline.


Related Documents

CPP0348 - Cardio-pulmonary Resuscitation- Adult Advanced Life Support
CPP0504 - Lidocaine - Intravenous Perioperative Acute Pain
CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPG0195 - Intravenous Drug Infusion Preparation Guide For Adults In ICU, ED, Theatre And CVU
CPP0544 - Intravenous Drug Administration And Classification List
POL0077 - Medication Management
CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
SOP0001 - Principles Of Clinical Care


References

Barwon Health (2019, February). Lidocaine (Lignocaine) for cardiac arrhythmias. Barwon Health. Personal communication received March 2019.
CRC Press Taylor & Francis Group. (2019). Renal Drug Database. Retrieved April 12, 2019 from
IBM Corporation. (2019). IBM Micromedex. Retrieved April 12, 2019, from
MIMS Online. (2019, April). MIMS Online, Min-I-jet Lignocaine Hydrochloride Injection product information. Retrieved April 12, 2019, from
MIMS Online. (2019, April). MIMS Online, Xylocaine® product information. Retrieved April 12, 2019, from
MIMS Online. (2019, April). MIMS Online, Xylocard® product information. Retrieved April 12, 2019, from
Rossi, S. (2019, January). Australian Medicines Handbook. Retrieved April 12, 2019, from
The Society of Hospital Pharmacists of Australia. (2019, February). Australian Injectable Drugs Handbook (7th ed.). Retrieved April 12, 2019, from
Therapeutic Guidelines Limited. (2018, March). Cardiovascular Guidelines. Retrieved April 12, 2019 from
Wolters Kluwer. (2019). UpToDate. Retrieved August 12, 2019, from


Appendix

Appendix 1- Lignocaine (lidocaine) - Intravenous and endotracheal – (cardiac)



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 30/09/2020
Review Responsibility: Pharmacist - Rotational Date for Review: 30/09/2024
Lignocaine (Lidocaine) Intravenous And Endotracheal (Cardiac) - DRG0028 - Version: 6 - (Generated On: 26-04-2025 05:46)